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Objective To assess the possible sexual transmission of virus and to identify the
prevalence of TTV viremia in Turkey and its association with other hepatotropic viruses.
Methods Serum samples were collected from 81 subjects (74 prostitutes and seven
homosexual men) at high risk of sexually transmitted infection and from 81 healthy
controls (74 females and seven males). Sera of patients and controls were tested for TTV,
hepatitis A virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency
virus. Also, serum alanine and aspartate aminotransferases were measured.
Results The prevalence rates of TTV viremia in the risk group and control group were
86.4% and 82.7%, respectively. There was a statistical difference in mean age between
TTV-infected and uninfected subjects (38.6 9.9 versus 32.2 6.1 years, respectively,
P< 0.001). Prevalence rates of TTV infection in subjects with positive anti-HAV and
positive anti-HBc were high when compared with subjects who were negative for these.
Conclusion We suggest that TTV infection has a diverse route of transmission, and its
prevalence increases with age; also, the prevalence rate of TTV is high in certain risk
groups. The prevalence rates of TTV in the group at risk for sexual transmission (86.4%)
and in the control group (82.7%) were among the highest ever reported in the world. Also,
we suggest that TTV generally does not cause clinical disease, in spite of this high
prevalence.
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I N T R O D U C T I O N
Transfusion-transmitted virus (TTV) is a DNA
virus that was discovered in three of five patients
with cryptogenic post-transfusion hepatitis by
Nishizawa et al. [1]. TTV has a high buoyant
density (1.26 g/cm3), single-stranded DNA that
consists of at least 3700 bases, and no outer envel-
ope [2]. These features of TTV resemble those of
the Parvoviridae, but TTV shows no sequence
homology with the Parvoviridae [3]. More recent
studies have shown that TTV has a diameter of 30–
50 nm, a circular, single-stranded DNA genome,
and a density in caesium chloride of 1.31–1.34 g/
cm3 [3]. These findings suggest that TTV resembles
the Circoviridae, which infect plants and verte-
brates [3].
In the past, transmission of virus was believed to
occur primarily by transfusion as well as other
parenteral routes. In the course of time, other
transmission routes, such as sexual, maternal,
and fecal–oral, and other contact, have been
demonstrated [4–9].
The reported seroprevalence of TTV in different
countries and in different risk groups varies greatly.
Reports from developed countries, such as North
America, Scotland and Japan, have shown that
the prevalence in healthy populations is 1–2%,
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whereas the prevalence is about 83% in rural
populations of Asian, African and South American
developing countries [4,5,10,11]. Another reported
feature of TTV prevalence is its correlation with
increasing age [5,6,12]. In contrast, in some other
studies, no relationship was found between age
and TTV positivity in different study populations
[13–15].
The first aim of this study was to assess the effect
of possible sexual transmission of virus on the
prevalence of TTV among prostitutes and homo-
sexual men. Second, we aimed to identify the
prevalence of TTV viremia and its association with
other hepatotropic viruses in the central Anatolia
region of Turkey.
M A T E R I A L S A N D M E T H O D S
Serum samples were collected from 81 subjects (74
prostitutes and seven homosexual men; mean age
38, range 24–65) at high risk of sexually trans-
mitted infection. Seventy-four females and seven
males (mean age 37, range 21–62) who requested
blood grouping at our hospital blood bank were
included as a control group. Serum samples were
stored at70 8C until they were used. Homosexual
men of our study group consisted of male prosti-
tutes. During the enrollment of the control group
to the study, the subjects were asked how many
sexual partners they had had until that time. The
candidates for the control group were informed
about the study and asked not be truthful about
the number of their sexual partners. Those who
had had only one sexual partner were included in
the study. Also, a Veneral Disease Research
Laboratory (VDRL) test was performed and ques-
tions about genital symptoms were asked, to
exclude possibility of sexually transmitted disease
(STD). Neither the sexual transmission risk group
(STRG) nor the control group had a history of
intravenous drug use.
Sample preparation and detection of TTV DNA
Sera of patients and controls (60 mL) were pre-
treated with pronase E and its buffer at 40 8C for
60 min, and then nucleic acids were extracted by
the alkali–phenol and chloroform method.
Extracted nucleic acids were dissolved in 20 mL
of DNase- and RNase-free deionized distilled
water and then subjected to PCR as described
previously [16]. In brief, the thermal cycler was
programmed to preheat at 95 8C for 10 min to
denature sample DNA, and then samples (10 mL
of extracted DNA mixed with 2.0 mM MgCl2,
30 pmol of each primer, sense and antisense, 2 U
of Taq polymerase, 10 mM dNTP) were subjected to
45 cycles consisting of 94 8C for 20 s, 60 8C for 20 s,
and 72 8C for 30 s in an MJ Research thermal cycler
(MJ Research Inc., Waltham, MA, USA). The
sequences of the TTV-specific primers from 50-
UTR were T801 (50-GCb ACG TCA CTA AC-
C ACG TG-30, sense primer, nucleotides 6–25)
and T935 (50-CTb CGG TGT GTA AAC TCA CC-
30, antisense primer, nucleotides 204–85; b¼G, C
or T), as designed by Takahashi et al. [16]. Multiple
positive and negative controls were run in each
PCR assay. Positive controls, which had been
obtained and stored at 80 8C in the previous
studies, were used. Also, the gene region used
for PCR cloned to PCR 2.1 plasmid for determina-
tion of sensitivity and it was used as a positive
control. The sensitivity of PCR was determined as
10–100 copy/mL in a PCR–TTV sensitivity test
performed with cloned TTV plasmid (PCR
2.1þTTV Amplicon, Topo TA cloning kit, Invitro-
gen, Carlsbad, CA, USA). PCR products (199 bp in
length) were analyzed by 2% agarose gel electro-
phoresis after ethidium bromide staining, and
photographed under UV light.
Detection of other virologic markers
Each sample was tested for anti-HAV IgG by
ELISA (Bioelisa HAV, Biokit, Barcelona, Spain).
In addition, each sample was tested for HBsAg
(Murex HBsAg Version 3, Abbott/Murex,
Dartford, UK), anti-HBc IgG (Wellcozyme anti-
HBc, Abbott/Murex), anti-HCV (Innotest HCV
Ab IV, Innogenetics, Gent, Belgium), and anti-
HIV 1/2 (Innotest HIV-1/HIV-2 Ab sp., Innoge-
netics, Belgium), by enzyme immunoassay.
Assays of aminotransferases
Serum alanine aminotransferase (ALT) and aspar-
tate aminotransferase (AST) were measured by
autoanalyzer (Hitachi 917, Roche Diagnostics,
Mannheim, Germany).
Statistical analysis
The Mann–Whitney U-test, Student’s t-test, the
chi-square test, Fisher’s Exact Test or the logistic
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regression test were used to analyze the data
where appropriate. A P-value of less than 0.05
was considered significant.
R E S U L T S
TTV DNA was detected in 70 (86.4%) of 81 subjects
(prostitutes 64/74, homosexual men 6/7) (Table 1).
Of the 81 control subjects, 67 (82.7%) had positive
results for TTV DNA (females 62/74, males 5/7).
The difference in the prevalence rates of TTV
viremia between the STRG and control group
was not statistically significant (P> 0.05). There
was no statistical difference in age between these
two groups (STRG 38.2 9.8 years; control group
37.0 9.7 years). However, there was a statistical
difference in age between TTV-infected and unin-
fected subjects (38.6 9.9 versus 32.2 6.1 years,
P¼ 0.002, Table 2). Logistic regression analysis
showed that TTV prevalence increases with
increasing age (r¼ 0.1894, P< 0.05).
The prevalence rates of positive anti-HAV
results in both groups were similar (STRG, 48/
81 (59.3%); controls, 45/81 (55.6%); P> 0.05;
Table 1). The TTV prevalence rates in the STRG
and in all study subjects (STRG plus control group)
with positive anti-HAV were statistically higher
than in those with negative anti-HAV (P¼ 0.043
and P¼ 0.005, respectively; Table 2). The preva-
lence rates of positive anti-HBc results in both
groups were statistically different (65.4% versus
35.8%; P< 0.001; Table 1). The TTV prevalence
rates in the STRG and in all study subjects with
positive anti-HBc were statistically higher than in
those with negative anti-HBc (P¼ 0.007 and
P¼ 0.004, respectively; Table 2).
A positive anti-HCV result was obtained in one
subject each from the STRG and control group.
However, HCV RNA assays in both cases were
negative with PCR. None of the subjects from the
STRG or control group had anti-HIV. Serum ALT
and AST levels were normal in all study subjects,
but not in one subject (ALT 54 U/L; AST 82 U/L).
This 31-year-old-prostitute had positive TTV only.
D I S C U S S I O N
When Nishizawa et al. first described TTV in
patients with cryptogenic post-transfusion hepa-
titis [1], it was believed that virus transmission was
Table 1 General features and viral
serologic results of groups STRG
n¼ 81
Control group
n¼ 81 P
Male/Female 7/74 7/74
Age (mean SD years) 38.2 9.8 37.0 9.7 >0.05a
Positive TTV DNA 70 (86.4%) 67 (82.7%) >0.05b
Positive anti-HAV 48 (59.3%) 45 (55.6%) >0.05b
Positive HbsAg 5 (6.2%) 4 (4.9%) >0.05c
Positive anti-HBc 53 (65.4%) 29 (35.8%) <0.001b
Positive anti-HCV 1 (1.2%) 1 (1.2%)
Positive anti-HIV 0 0
at-test; bchi-square test; cFisher’s Exact Test. STRG, sexual transmission risk
group.
Table 2 Comparison of TTV DNA-
positive and -negative study sub-
jects Risk factors n
TTV DNA
Positive
TTV DNA
Negative P
Age (mean SD, years) 137/25 38.6 9.9 32.2 6.1 ¼0.002a
STRG 70/11 39.1 9.9 32.3 6.4 ¼0.031b
Control group 67/14 38.0 10.1 32.1 6.1 ¼0.038a
Positive/negative anti-HAV 93/69 85/52 8/17 ¼0.005c
STRG 48/33 45/25 3/8 ¼0.043d
Control group 45/36 40/27 5/9 >0.05c
Positive/negative anti-HBc 82/80 76/61 6/19 ¼0.004c
STRG 53/28 50/20 3/8 ¼0.007d
Control group 29/52 26/41 3/11 >0.05d
aMann–Whitney U-test; bt-test, cchi-square test; dFisher’s Exact Test. STRG,
sexual transmission risk group.
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via transfusion. However, more recent studies
have shown that there are diverse routes of trans-
mission of TTV [4–9].
In our study, the prevalence rate of TTV in a
sexual transmission risk group was slightly higher
than in controls, but the difference was not statis-
tically significant (86.4% versus 82.7%). Our find-
ing was in agreement with those of MacDonald
et al. [12], who also found no statistical difference
between patients at risk for sexual transmission
(52 prostitutes, 81 homosexual men) and normal
controls, but their prevalence rates (13.4% and
9.8% versus 4.5%, P> 0.05) were very low when
compared with ours. On the other hand, Huang
et al. reported that the prevalence rate of TTV in
prostitutes was significantly higher than in the
control group (32.9% versus 21.3%) [13]. In our
study, the prevalence rate of TTV in normal con-
trol subjects was one of the highest ever reported
(82.7%). Previous reports on prevalence from dif-
ferent countries indicate that the prevalence is
high in the developing countries [4,5,10,11]. In
another study, TTV seroepidemiology was
assessed in individuals, including healthy popula-
tions and different risk groups from ten different
geographic regions [17]. The prevalence rates
found in that study varied from 70% to 100%.
The probable reason for the very different results
obtained in prevalence studies performed in the
same geographic area with similar groups is the
type of primer used in the TTV PCR tests. Previous
techniques had low sensitivity and unstable reac-
tions. To overcome this problem, a more sensitive
and stable new primer combination was devel-
oped by Takahashi et al. [16]. Using their new PCR
system, they reported that the prevalence of TTV
in healthy individuals in Japan was 92% [16].
The prevalence rates of other hepatotropic
viruses, but not hepatitis B virus (HBV), were
similar in both groups. The prevalence rate of
HBV was significantly higher in the STRG. This
high prevalence showed the efficacy of the sexual
transmission route for HBV.
We found that the mean age of subjects who
were TTV positive was significantly higher than
that of subjects who were TTV negative, and that
TTV prevalence increased with advanced age. This
finding was in agreement with many reports
showing that the TTV prevalence rate was high
in older age groups [5,6,12]. In contrast, there are
reports showing no association between age and
TTV viremia [13–15]. The lack of relationship
between age and TTV positivity in these studies
may be explained by the low prevalence of TTV in
the populations studied.
Our results showed significantly higher preva-
lence rates of TTV infection in subjects positive for
anti-HAV and anti-HBc when compared to sub-
jects with negative anti-HAV and negative anti-
HBc (91.4% versus 75.4%, and 92.7% versus 76.3%,
respectively). This high prevalence of virus in
subjects with anti-HAV and anti-HBc suggests that
TTV may share common modes of transmission
with HAV and HBV. According to our results,
transmission of TTV via sexual contact was not
as efficient as transmission of HBV in our study
population. However, these findings suggest that
sexual transmission has at least a minor role in
TTV transmission.
The prevalence rate of hepatitis C virus (HCV)
in our study subjects was very low, and we were
not able to establish any association between TTV
and HCV infection. However, Kao et al. showed an
increased prevalence of TTV infection in patients
with chronic HCV infection [18]. Another report
from Japan also showed an increased frequency of
TTV viremia in patients with HCV infection [10].
All of the subjects, except for one prostitute, had
no biochemical evidence of liver disease. This
finding suggests that TTV, like the hepatitis G
virus, has no clear disease association. Similarly,
there are some reports showing TTV viremia to
have no relationship to liver disease or hepatocel-
lular carcinoma [4,10,19,20]. On the other hand,
Charlton et al. found an increased prevalence of
TTV in patients with liver disease, including cryp-
togenic cirrhosis and fulminant hepatic failure [4].
Christensen et al. investigated the pathogenic role
of TTV in patients with human immunodeficiency
virus. They found an association between high
TTV viremia and decreased survival, and sug-
gested that TTV may be an opportunistic pathogen
[21].
In one study, vertical transmission of TTV was
assessed and 19% of cord bloods were found to be
TTV infected [6]. TTV viremia in 68 children was
assessed in plasma samples collected in the 3rd
and 12th months after birth in a rural area of the
Democratic Republic of Congo [14]: 37 children
became TTV infected after 3 months of age, while
TTV viremia was detected in only two children in
the 3-month samples. These data suggest that an
environmental source of TTV infection, rather than
vertical transmission seems to be more likely.
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Okamoto et al. showed that TTV transmission via
the fecal–oral route is also possible [7]. They
detected TTV DNA in feces from three of five
patients with post-transfusion non-A–G hepatitis.
All of these data, as well as our own, indicate
that TTV infection has diverse routes of transmis-
sion, its prevalence increases with age, and the
prevalence rate of TTV is high in certain risk
groups such as patients with hepatitis A–E, pros-
titutes and homosexual men. Although the pre-
valence rates of TTV in developing or
underdeveloped countries are higher than in
developed countries, TTV viremia is widespread
in the world. The TTV prevalence rate in normal
controls was found to be very high (82.7%) in the
central Anatolia region of Turkey. There was no
obvious evidence of clinical disease in spite of this
high prevalence rate.
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